Drug Profile
Diclofenac ophthalmic - InSite Vision
Alternative Names: ISV-205Latest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator InSite Vision
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; TIGR protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Glaucoma; Ocular inflammation; Ocular pain
Most Recent Events
- 31 Dec 2006 This programme is still in active development for ocular pain and inflammation
- 12 Dec 2004 Suspended - Phase-II for Glaucoma in USA (Ophthalmic)
- 31 Dec 2002 Preclinical trials in Ocular inflammation in USA (Ophthalmic)